$116.80
00.00%
Pre-Market: 5:24 PM EDT
15 minutes delayed
Abbott Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Abbott Laboratories using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-16 | $1.21 | $1.20 | 0.83 % |
Jun 2024 | 2024-07-18 | $1.14 | $1.10 | 3.64 % |
Mar 2024 | 2024-04-17 | $0.98 | $0.95 | 3.16 % |
Dec 2023 | 2024-01-24 | $1.19 | $1.19 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-10-16 | $10.64B | $10.55B | 0.81 % |
Jun 2024 | 2024-07-18 | $10.38B | $10.37B | 0.07 % |
Mar 2024 | 2024-04-17 | $9.96B | $9.88B | 0.85 % |
Dec 2023 | 2024-01-24 | $10.24B | $10.18B | 0.60 % |
Abbott Laboratories (ABT) is scheduled to report earnings on January 22, 2025. The last reported earnings were for reported on October 16, 2024 for Q3.
The Actual EPS was $1.21, which beat the estimate of $1.20.
The Actual Revenue was $10.6B, which beat the estimate of $10.6B.
Browse earnings estimates, EPS, and revenue on all stocks.